Related Experiment Video
Updated: Aug 27, 2025
Urethral Stricture Induction Followed by Buccal Mucosa Graft Urethroplasty in a Rat Model
Published on: April 28, 2023
Dexmededomidine in pediatric unilateral internal inguinal ring ligation
Guang Liu1, Ling Zhang1, Hui-Se Wang1
1Department of Anesthesiology, Baoding Children's Hospital, Baoding 071000, Hebei Province, China.
Insights
Dexmedetomidine monotherapy provides comparable pain relief to sufentanil for pediatric inguinal hernia surgery. It offers better sedation and fewer side effects like nausea and vomiting.
Area of Science:
- Pediatric Surgery
- Anesthesiology
- Pain Management
Background:
- Effective postoperative analgesia is crucial for pediatric inguinal hernia repair.
- Optimizing pain management strategies minimizes patient discomfort and improves recovery.
Purpose of the Study:
- To evaluate the safety and efficacy of dexmedetomidine as a sole agent for postoperative pain relief.
- To compare dexmedetomidine monotherapy with sufentanil or a combination of both in children undergoing laparoscopic inguinal hernia ligation.
Main Methods:
- A randomized controlled trial involving 390 children aged 1-3 years (ASA grade I-II).
- Participants were assigned to receive dexmedetomidine, dexmedetomidine plus sufentanil, or sufentanil alone.
- The primary outcome was the proportion of patients with a low pain score (FLACC ≤ 3) at 2 hours post-surgery.
Main Results:
- No significant differences in pain scores (FLACC) were observed among the three groups at multiple time points (2-24 hours).
- Dexmedetomidine monotherapy demonstrated superior sedative effects compared to sufentanil alone.
- The incidence of nausea and vomiting was significantly lower in the dexmedetomidine group.
Conclusions:
- Dexmedetomidine monotherapy is a viable option for postoperative analgesia in pediatric inguinal hernia surgery.
- It offers comparable pain management to sufentanil, with added benefits of improved sedation and reduced adverse events.
- This suggests dexmedetomidine monotherapy as a potentially advantageous analgesic strategy in this patient population.
Background:
Safe and effective analgesia strategy remains one of the priorities for pediatric inguinal hernia treatment.
Aim:
To explore safety and efficacy of dexmededomidine monotherapy for postoperative analgesia in children who received laparoscopic unilateral internal inguinal ring ligation.
Methods:
This randomized single-center controlled trial included 390 children (aged 1-3 years, ASA grade I-II), randomly divided into a dexmededomidine group (D group), a dexmededomidine + sufentanil group (DS group), and a sufentanil group (S group). The primary endpoint was percentage of children with the Face, Legs, Activity, Cry, and Consolability (FLACC) score ≤ 3 points 2 h after surgery.
Results:
The comparisons of the FLACC scores at 2, 4, 6, 8, 12, and 24 h were not significantly different among the three groups (P > 0.05). The sedative effects in the D group were significantly better than those in the S group (P > 0.05), but not significantly different from those in the DS group. The incidence of nausea and vomiting was significantly lower in the D group than in the S group and DS group (P > 0.05).
Conclusion:
Analgesic effects of dexmededomidine monotherapy are comparable to those of sufentanil alone or in combination with dexmededomidine for children who underwent laparoscopic unilateral internal inguinal ring ligation, with better sedative effects and a lower incidence of adverse events.
